Clinical
United States
A Feasibility Study (NCT02296580) of the EMulate Therapeutics Voyager System in Patients with
Recurrent Glioblastoma Multiforme (rGBM).
This study is closed and NOT recruiting any further patients.
Find out more: https://clinicaltrials.gov/ct2/show/NCT02296580
Australia
A Feasibility Study (NCT02507102) of the EMulate Therapeutics Voyager System in Patients with
Recurrent Glioblastoma Multiforme (rGBM).
This study is closed and NOT recruiting any further patients.
Find out more: https://www.clinicaltrials.gov/ct2/show/NCT02507102
Research Partners
Clinical Trial
A Feasibility Study of the EMulate Therapeutics Voyager System in Patients with Recurrent Glioblastoma Multiforme (rGBM). This study is currently recruiting qualified patients.
Learn MoreResearch Spotlight
Abstract presented by Xavier Figueroa, PhD, at Society for Neuro-Oncology 2016 Annual Conference, Scottsdale, AZ on November 19, 2016.
LEARN MOREPublications
The latest information on publications highlighting EMulate Therapeutics research and advancements.
Read More